Figure 2B–F illustrates our results. VEGFR2 expression rose with higher Gleason scores in a highly significant manner (Figure 2B) among high-risk PCa samples. We additionally analyzed VEGFR2 and miR-221 levels depending on the endpoint. Regarding clinical progress, while PCa patients suffering from progression had significantly higher VEGFR2 levels (p = 0.034), miR-221 levels in these patients decreased in a highly significant manner (p = 0.00001, Figure 2C), as described previously [8,12]. Here, KDR is linked to posterior cortical atrophy.